PROTECH SOLUTION

Dosage

Children: Refer to BNF for Children for appropriate dosing guidelines, as specific therapeutic doses are not applicable for butane.

Adults: Refer to BNF for appropriate dosing guidelines, as specific therapeutic doses are not applicable for butane.

Mechanism of action

Butane acts primarily as a central nervous system depressant when inhaled, leading to hypoxia and potential cardiac complications. The inhalation of butane can result in a range of toxic effects, including asphyxia due to displacement of oxygen and direct toxic effects on cardiac tissues, which can lead to arrhythmias and myocardial damage.

Pharmacodynamics

The pharmacodynamic properties of butane involve its effects on the central nervous system, where it enhances inhibitory neurotransmission. This can lead to sedation and a decreased level of consciousness. Additionally, butane can cause cardiovascular effects, including changes in heart rhythm and potential myocardial ischemia due to oxygen deprivation.

Pharmacokinetics

Butane is rapidly absorbed through the lungs upon inhalation. Its distribution throughout the body is quick due to its lipophilic characteristics, allowing it to cross cell membranes efficiently. Metabolism of butane occurs primarily in the liver, although specific metabolic pathways are not extensively characterized. The elimination half-life is variable and dependent on the duration and intensity of exposure.

Contra-indications

• Hypersensitivity to butane or any of its components
• Severe respiratory insufficiency
• Acute or chronic pulmonary disease

Adverse effects

• Asphyxia
• Cardiac arrhythmias
• CNS depression
• Dizziness
• Headache
• Nausea
• Vomiting
• Confusion
• Loss of consciousness

Interactions

• May potentiate the effects of other CNS depressants
• Use with caution in patients receiving medications that affect cardiac rhythm

Precautions

• Use in well-ventilated areas to reduce inhalation risk
• Monitor patients for signs of respiratory distress
• Avoid use in individuals with a history of substance abuse

Pregnancy

There are no adequate and well-controlled studies in pregnant women. Use only if clearly needed and the potential benefits justify the potential risks.

Breast-feeding

It is not known whether butane is excreted in human milk. Caution should be exercised when administered to a nursing woman.

Storage

Store in a cool, well-ventilated area away from heat and flames. Keep container tightly closed.

Formulations

• Aerosol propellant
• Lighter refills

Indications

• Dermatological conditions
• Potential anti-inflammatory applications

Dosage

Children: Refer to the BNF for Children for specific recommendations.

Adults: Refer to the BNF for specific recommendations.

Mechanism of action

The precise mechanism of action of toluamide is not well-documented in existing literature. However, as an amide derivative, it is hypothesized to interact with biological membranes and may influence cellular signaling pathways, potentially leading to anti-inflammatory effects.

Pharmacodynamics

Toluamide may exhibit pharmacodynamic properties associated with its amide structure, including modulation of inflammatory responses. Its effects on cellular processes are likely mediated through interactions with specific receptors or enzymes, although detailed pathways are not extensively characterized in the current pharmacological literature.

Pharmacokinetics

The pharmacokinetics of toluamide have not been extensively studied. General principles of amide compounds suggest that they may have moderate absorption and distribution characteristics, with potential metabolism in the liver. The elimination half-life and excretion route remain unspecified, requiring further research to clarify these parameters.

Pregnancy

There is limited data on the safety of toluamide in pregnancy. Use only if the potential benefit justifies the risk to the fetus.

Breast-feeding

There is insufficient information on the excretion of toluamide in human milk. Caution is advised when administering to breastfeeding women.

Storage

Store in a tightly closed container, in a cool, dry place away from light.

Formulations

• {'formulation': 'Toluamide', 'molecular_formula': 'C8H9NO'}

Mechanism of action

...Not infrequently intentional butane inhalation results in high morbidity and mortality. A fatal outcome of butane abuse can be caused by asphyxia, cardiac arrhythmia or trauma. The reported number of cases in which death was the consequence of pure butane inhalation is limited, and in most cases a mixture of propellants was involved. This report covers two cases of sudden death due to the sniffing of a cigarette lighter refill containing butane. Autopsy was followed by toxicological, pathohistological and immunohistochemical analysis. Butane gas was confirmed in samples of blood, urine, brain and lungs... Histology showed almost identical changes in the lungs and heart in both cases. The morphology of heart damage on standard H/E stains was of special interest because it displayed all the characteristics of chronic and acute myocardial hypoxia found in the absence of atherosclerotic heart disease. In order to confirm early cardiac death caused by asphyxia due to butane inhalation a panel of immunohistochemical agents was used...